Bermekimab Uses, Dosage, Side Effects and more
Bermekimab is under investigation in clinical trial NCT01384630 (Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis).
| Trade Name | Bermekimab |
| Generic | Bermekimab |
| Bermekimab Other Names | Bermekimab, RA-18C3 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
